Health TrialsbyHealthPanel

Aerobic Exercise Addition to Cognitive Behavioural Treatment in Impotence Metabolic-syndrome Drinkers

ConditionsHeavy DrinkingMetabolic SyndromeImpotence
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age35-45
SponsorCairo University

About this trial

Cognitive Behavioural Treatment is used as treatment for Heavy Drinking, Impotence, and Metabolic Syndrome. The efficacy of adding aerobic training to this treatment is not tested till now.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

heavy drinking men (forty)

men who complain metabolic syndrome

men who complain impotence

Disqualifiers

cardiac problems

renal or hepatic or respiratory or neurogenic diseases,

Trial design

Design model

Parallel

Treatments tested in this trial

  • aerobci physical training and cognitive behavioural treatment

    Behavioral

    Twenty men with Heavy Drinking, Impotence, and Metabolic Syndrome receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks). Also, men will also adminsiter supervised aerobic training (walking on electrical treamill, 50 minute per the session, three times/week, for 12 weeks).

  • Cognitive behavioural treatment

    Behavioral

    Twenty men with Heavy Drinking, Impotence, and Metabolic Syndrome will receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks)

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: group number 1Experimental treatment 1 intervention
Group B: group number 2Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

international index of erectile function

it contain 5 questions that will assess penile erectile functions

Time frame
it will be measured after 12 weeks

Secondary outcomes

1

body mass index

it will be assessed on empty stomach and empty bladder and empty bowel

Time frame
It will be measured after 12 weeks
2

waist circumference

it will be assessed at ubmlilicus by a tape

Time frame
It will be measured after 12 weeks
3

blood systolic pressure

it will be assessed via sphygmonameter

Time frame
It will be measured after 12 weeks
4

blood diastolic pressure

it will be assessed via sphygmonameter

Time frame
it will be measured after 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov
Apply now